Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav.
Couñago F, de Dios NR, Montemuiño S, Jové-Teixidó J, Martin M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, Díaz-Díaz V, de Ingunza-Barón L, Murcia-Mejía M, Alcántara P, Corona J, Puertas MM, Chust M, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Taboada B. Couñago F, et al. Among authors: martin m. Lung Cancer. 2018 Sep;123:174-175. doi: 10.1016/j.lungcan.2018.06.031. Epub 2018 Jul 13. Lung Cancer. 2018. PMID: 30017426 No abstract available.
Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F, Rodriguez de Dios N, Montemuiño S, Jové-Teixidó J, Martin M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, Díaz-Díaz V, de Ingunza-Barón L, Murcia-Mejía M, Alcántara P, Corona J, Puertas MM, Chust M, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Taboada B. Couñago F, et al. Among authors: martin m. Lung Cancer. 2018 Apr;118:119-127. doi: 10.1016/j.lungcan.2018.02.008. Epub 2018 Feb 14. Lung Cancer. 2018. PMID: 29571989 Free article.
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F, Montemuiño S, Martin M, Taboada B, Calvo-Crespo P, Samper-Ots MP, Alcántara P, Corona J, López-Guerra JL, Murcia-Mejía M, López-Mata M, Jové-Teixidó J, Chust M, Díaz-Díaz V, de Ingunza-Barón L, García-Cañibano T, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Puertas MM, Thuissard IJ, Sanz-Rosa D, de Dios NR. Couñago F, et al. Among authors: martin m. Clin Transl Oncol. 2019 Jun;21(6):735-744. doi: 10.1007/s12094-018-1976-3. Epub 2018 Nov 14. Clin Transl Oncol. 2019. PMID: 30430394
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index.
Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, Plasencia JM, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, de la Haba I, Antonio M, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, Ayala de la Peña F, Vicente V. Carmona-Bayonas A, et al. Among authors: martin m. Br J Cancer. 2017 Apr 11;116(8):994-1001. doi: 10.1038/bjc.2017.48. Epub 2017 Mar 7. Br J Cancer. 2017. PMID: 28267709 Free PMC article.
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.
Garde-Noguera J, Martin-Martorell P, De Julián M, Perez-Altozano J, Salvador-Coloma C, García-Sanchez J, Insa-Molla A, Martín M, Mielgo-Rubio X, Marin-Liebana S, Blasco-Cordellat A, Blasco-Molla S, Gironés R, Marquez-Medina D, Aparisi F, Cerda MCB, Macia-Escalante S, Sánchez A, Juan-Vidal O. Garde-Noguera J, et al. Among authors: martin m, martin martorell p. Clin Transl Oncol. 2018 Aug;20(8):1072-1079. doi: 10.1007/s12094-017-1829-5. Epub 2018 Jan 24. Clin Transl Oncol. 2018. PMID: 29368144
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.
Chan A, Martin M, Untch M, Gil MG, Guillem-Porta V, Wojtukiewicz M, Kellokumpu-Lehtinen P, Sommer HL, Georgoulias V, Battelli N, Pawlicki M, Aubert D, Bourlard T, Gasmi J, Villanova G, Petruzelka L; Navelbine Herceptin Project. Chan A, et al. Among authors: martin m. Br J Cancer. 2006 Oct 9;95(7):788-93. doi: 10.1038/sj.bjc.6603351. Epub 2006 Sep 12. Br J Cancer. 2006. PMID: 16969343 Free PMC article. Clinical Trial.
12,848 results
You have reached the last available page of results. Please see the User Guide for more information.